4.4 Article

Novel heterozygous mutation c.4282G>T in the SCN5A gene in a family with Brugada syndrome

期刊

EXPERIMENTAL AND THERAPEUTIC MEDICINE
卷 9, 期 5, 页码 1639-1645

出版社

SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2015.2361

关键词

Brugada syndrome; SCN5A; heterozygous mutation

资金

  1. National Natural Science Foundation of China [31301024, 81400462]
  2. Natural Science Foundation of Hubei Province of China [2012FKB02441]

向作者/读者索取更多资源

Brugada syndrome (BrS) is a rare, inherited arrhythmia syndrome. The most well-known gene that is responsible for causing BrS is SCN5A, which encodes the human cardiac Na+ channel (Na(v)1.5) alpha subunit. To date, it has been reported that >100 mutations in SCN5A can cause BrS. In the present study, a novel BrS-associated Na(v)1.5 mutation, A1428S, was identified in a proband who was successfully resuscitated from an episode of sudden collapse during walking. This mutation was further confirmed by polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis, which showed that the PCR fragment containing the mutation A1428S could be cut by the restriction enzyme Nsi1, yielding two shorter DNA fragments of 329 and 159 bp, which were not present in family members homozygous for the wild-type (WT) allele. Furthermore, the electrophysiological properties were analyzed by patch clamp technique. Current density was decreased in the A1428S mutant compared that in the WT. However, neither the steady-state activation or inactivation, nor the recovery from inactivation exhibited changes between the A1428S mutant and the WT. In conclusion, the results of this study are consistent with the hypothesis that a reduction in Na(v)1.5 channel function is involved in the pathogenesis of BrS. The structural-functional study of the Na(v)1.5 channel enhances the present understanding the pathophysiological function of the channel.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据